VALO HEALTH

WIPO WIPO 2020

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke VALO HEALTH wurde als Wortmarke am 03.12.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 29. März 2023

Markenform Wortmarke
Aktenzeichen 1570709
Länder Australien Kanada Schweiz China Europäische Gemeinschaft Großbritannien Israel Japan Singapur
Basismarke US Nr. 88945793, 03. Juni 2020
Anmeldedatum 03. Dezember 2020
Ablaufdatum 03. Dezember 2030

Markeninhaber

399 Boylston Street, Suite 505
Boston MA 02116
US

Markenvertreter

151 W 42nd St., 17th Floor New York NY 10036 US

Waren und Dienstleistungen

01 Chemical and biological agents for scientific and research use
05 Pharmaceutical preparations for treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders and therapeutic agents for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders
09 Downloadable computer software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, biology, biochemistry
36 Venture capital funding services to emerging and start-up companies; providing venture capital, development capital, private equity and investment funding; venture capital advisory services; hedge fund investment services
42 Pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceutical preparations and substances for use in clinical trials; providing on-line non-downloadable computer software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing on-line non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, biology, biochemistry
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
20. März 2023 2023/13 Gaz AU Ablehnung
06. Mai 2022 2022/19 Gaz CA Ablehnung
28. April 2022 2022/18 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
26. April 2022 2022/23 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
02. März 2022 2022/13 Gaz IL RAW: Rule 18ter(2)(ii) GP following a provisional refusal
23. Dezember 2021 2021/52 Gaz CH Ablehnung
25. November 2021 2021/47 Gaz JP Ablehnung
10. Oktober 2021 2021/42 Gaz IL Ablehnung
16. September 2021 2021/37 Gaz GB Ablehnung
02. Juni 2021 2021/22 Gaz EM Ablehnung
26. Mai 2021 2021/22 Gaz SG Ablehnung
19. Mai 2021 2021/26 Gaz CN Ablehnung
29. April 2021 2021/19 Gaz IL Ablehnung
12. Februar 2021 2021/7 Gaz AU Ablehnung
03. Dezember 2020 2020/53 Gaz US Eintragung

ID: 141570709